APA (7th ed.) Citation

Giorgio Zauli, Veronica Tisato, & Paola Secchiero. (2020). Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Giorgio Zauli, Veronica Tisato, and Paola Secchiero. Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients. Frontiers Media S.A., 2020.

MLA (9th ed.) Citation

Giorgio Zauli, et al. Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients. Frontiers Media S.A., 2020.